In the subcutaneous homograft and liver orthotopic transplantation mouse models of Hepa1‐6 cells, the inhibitor of STAT3 napabucasin effectively suppressed tumour growth and prolonged the survival of HCC mice. This evidence concerns the gene STAT3 and hepatocellular carcinoma.